OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Home » Week of 3/13/23-3/17/23
Credit ratings are not currently available for public cannabis companies leaving companies, lenders and investors with a gap of information. The Viridian Cannabis Credit Tracker fills this gap. The model uses 11 market and financial statement variables to discern 4 key credit factors: Liquidity, Leverage, Profitability, and Size, to provide credit/liquidity analysis for over 370 public Cannabis/Hemp companies.
The Viridian Credit Tracker utilizes 11 different bespoke credit ratios to evaluate four aspects of credit quality: Liquidity, Leverage, Profitability, and Size. We are looking at the extreme quartiles of our ratios to identify credit stresses. Our favorite leverage indicator is total liabilities/ market cap. We prefer to use total liabilities rather than total debt, because the former picks up both lease liabilities and tax liabilities. We have found that 3x on this ratio signals significant chances of credit issues. Of the 24 companies we track in the Infused Products & Extracts sector, the six companies have measures over 7.3x. Five of these also have free cash flow adjusted current ratios below 1.0x, indicating a probable need for additional financing within the year. The five are all small companies; the largest is Gaby Inc. (GABY: CSE), the $2.8M market cap parent company of San Diego’s Mankind Dispensary. Gaby has over 16x Liabilities/mkt cap and a free cash flow adjusted current ratio of .14. Gaby has a $25.5M promissory note payable to the sellers of the Mankind dispensary. Approximately $5.0M is due in April 2023. Gaby management is in discussions with to the holders of the note to restructure payments.
The Viridian Credit Tracker utilizes 11 different bespoke credit ratios to evaluate four aspects of credit quality: Liquidity, Leverage, Profitability, and Size. We are looking at the extreme quartiles of our ratios to identify credit stresses. Our favorite leverage indicator is total liabilities/ market cap. We prefer to use total liabilities rather than total debt, because the former picks up both lease liabilities and tax liabilities. We have found that 3x on this ratio signals significant chances of credit issues. Of the 24 companies we track in the Infused Products & Extracts sector, the six companies have measures over 7.3x. Five of these also have free cash flow adjusted current ratios below 1.0x, indicating a probable need for additional financing within the year. The five are all small companies; the largest is Gaby Inc. (GABY: CSE), the $2.8M market cap parent company of San Diego’s Mankind Dispensary. Gaby has over 16x Liabilities/mkt cap and a free cash flow adjusted current ratio of .14. Gaby has a $25.5M promissory note payable to the sellers of the Mankind dispensary. Approximately $5.0M is due in April 2023. Gaby management is in discussions with to the holders of the note to restructure payments.
*Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.
Copyright Viridian Capital Advisors © 2022